Nuwellis (NUWE) Net Cash Flow Growth (5y) (2016 - 2026)
Nuwellis (NUWE) Net Cash Flow Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn |
| 10 | Nuwellis | 115,607.70 | -1.97 Mn | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.56% |
| Dec 31, 2025 | 10.91% |
| Sep 30, 2025 | -16.37% |
| Jun 30, 2025 | -2.50% |
| Mar 31, 2025 | -20.85% |
| Dec 31, 2024 | 27.41% |
| Sep 30, 2024 | 17.46% |
| Jun 30, 2024 | 37.97% |
| Mar 31, 2024 | -19.11% |
| Dec 31, 2023 | 16.34% |
| Sep 30, 2023 | -39.22% |
| Jun 30, 2023 | 5.66% |
| Mar 31, 2023 | -4.06% |
| Dec 31, 2022 | 10.09% |
| Sep 30, 2022 | -1.59% |
| Jun 30, 2022 | -24.70% |
| Mar 31, 2022 | -75.20% |
| Dec 31, 2021 | -107.64% |
| Sep 30, 2021 | 19.09% |
| Jun 30, 2021 | 2.38% |